DR. ELLEN SIDRANSKY, M.D.
Medical Practice in Bethesda, MD
License number
Maryland MD17189
Category
Medical Practice
Type
Clinical Genetics (M.D.)
Address
Address
351A213 Convent Dr, Bethesda, MD 20892
Phone
(301) 451-0901
(301) 402-6438 (Fax)
(301) 402-6438 (Fax)
Personal information
See more information about ELLEN SIDRANSKY at radaris.comName
Address
Phone
9214 Chanute Dr, Bethesda, MD 20814
9414 Linden Ave, Bethesda, MD 20814
Organization information
See more information about ELLEN SIDRANSKY at bizstanding.comEllen Sidransky MD
35 Convent Dr #1A213, Bethesda, MD 20892
Categories:
Physicians & Surgeons
Site:
Phone:
(301) 496-0373 (Phone)
Professional information
Dr. Ellen Sidransky, Bethesda MD - MD (Doctor of Medicine)
Specialties:
Pediatrics, Clinical Genetics
Address:
351A213 Convent Dr, Bethesda 20892
(301) 451-0901 (Phone), (301) 402-6438 (Fax)
(301) 451-0901 (Phone), (301) 402-6438 (Fax)
Certifications:
Clinical Genetics, 1990, Pediatrics, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Tulane University of Louisiana
Graduated: 1981
Tulane University of Louisiana
Graduated: 1981
Dna Sequence Surrounding The Glucocerebrosidase Gene
US Patent:
2003001, Jan 16, 2003
Filed:
Feb 22, 2001
Appl. No.:
09/790852
Inventors:
Edward Ginns - Bethesda MD, US
Ellen Sidransky - Bethesda MD, US
Suzanne Winfield - Rockville MD, US
Nahid Tayebi - Potomac MD, US
Brian Martin - Rockville MD, US
Ellen Sidransky - Bethesda MD, US
Suzanne Winfield - Rockville MD, US
Nahid Tayebi - Potomac MD, US
Brian Martin - Rockville MD, US
Assignee:
Department of Health and Human Sevices, c/o National Institutes of Health
International Classification:
C12N009/24, C07H021/04
US Classification:
435/200000, 435/069100, 435/320100, 536/023200
Abstract:
The present invention provides the discovery and isolation of the nucleotide sequence of the human clk2, the human propin1, and the human cote1 genes that are located within the glucocerebrosidase gene locus. Also provided by the present invention are proteins or polypeptides encoded by those genes, nucleic acids encoding those polypeptides, and antibodies to those proteins. Further provided by the present invention are nucleic acids of the same apparent molecular size as the propin1 and cote1 gene regions and which have the same restriction pattern as the wild-type genes.